These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32403962)

  • 1. The effect of antithrombotic therapy on the recurrence of placenta-mediated diseases in pregnancy.
    Neykova K; Dimitrova V; Dimitrov R
    J Matern Fetal Neonatal Med; 2022 Apr; 35(8):1462-1468. PubMed ID: 32403962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [ANTITHROMBOTIC MEDICATION IN PREGNANT WOMEN WITH PREVIOUS INTRAUTERINE GROWTH RESTRICTION].
    Neykova K; Dimitrova V; Dimitrov R; Vakrilova L
    Akush Ginekol (Sofiia); 2016; 55(2):3-9. PubMed ID: 27509650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA].
    Neikova K ; Dimitrova V; Dimitrov R; Savov A
    Akush Ginekol (Sofiia); 2015; 54(5):3-12. PubMed ID: 26411189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
    Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.
    Lefkou E; Mamopoulos A; Dagklis T; Vosnakis C; Rousso D; Girardi G
    J Clin Invest; 2016 Aug; 126(8):2933-40. PubMed ID: 27454295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone.
    Sergio F; Maria Clara D; Gabriella F; Giorgia S; Sara De Carolis ; Giancarlo P; Alessandro C
    Hypertens Pregnancy; 2006; 25(2):115-27. PubMed ID: 16867918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial.
    Llurba E; Bella M; Burgos J; Mazarico E; Gómez-Roig MD; De Diego R; Martínez-Astorquiza T; Alijotas-Reig J; Sánchez-Durán MÁ; Sánchez O; Carreras E; Cabero L
    Fetal Diagn Ther; 2020; 47(11):824-833. PubMed ID: 33472201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy.
    Urban G; Vergani P; Tironi R; Ceruti P; Vertemati E; Sala F; Pogliani E; Triche EW; Lockwood CJ; Paidas MJ
    Int J Fertil Womens Med; 2007; 52(2-3):59-67. PubMed ID: 18320863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study.
    Zhang Y; Shen F; Yang W; Wang J; Zhou J; Chen Y
    Int J Gynaecol Obstet; 2021 Aug; 154(2):337-342. PubMed ID: 33314052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis.
    Chen J; Huai J; Yang H
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):68. PubMed ID: 38233773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin for the Prevention of Preeclampsia and Intrauterine Growth Restriction.
    Roberge S; Odibo AO; Bujold E
    Clin Lab Med; 2016 Jun; 36(2):319-29. PubMed ID: 27235915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
    Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E
    Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications.
    Rodger MA; Carrier M; Le Gal G; Martinelli I; Perna A; Rey E; de Vries JI; Gris JC;
    Blood; 2014 Feb; 123(6):822-8. PubMed ID: 24357725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placenta-mediated pregnancy complications in women with a history of late fetal loss and placental infarction without thrombophilia: risk of recurrence and efficacy of pharmacological prophylactic interventions. A 10-year retrospective study.
    Borella F; Marozio L; Bertschy G; Botta G; Bertero L; Cassoni P; Maina A; Cosma S; Benedetto C
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2183748. PubMed ID: 36860098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.
    Cruz-Lemini M; Vázquez JC; Ullmo J; Llurba E
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1126-S1144.e17. PubMed ID: 34301348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: Is it time to put the needles away?
    Skeith L; Rodger M
    Thromb Res; 2017 Mar; 151 Suppl 1():S38-S42. PubMed ID: 28262232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.